Literature DB >> 30518570

Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block.

Robert M Clancy1, Marc Halushka2, Sara E Rasmussen3, Tenzin Lhakhang4, Miao Chang3, Jill P Buyon3.   

Abstract

Given that diseases associated with anti-SSA/Ro autoantibodies, such as systemic lupus erythematosus and Sjögren syndrome, are linked with an upregulation of IFN and type I IFN-stimulated genes, including sialic acid-binding Ig-like lectin 1 (Siglec-1), a receptor on monocytes/macrophages, recent attention has focused on a potential role for IFN and IFN-stimulated genes in the pathogenesis of congenital heart block (CHB). Accordingly, three approaches were leveraged to address the association of IFN, IFN-stimulated genes, and the phenotype of macrophages in affected fetal cardiac tissue: 1) cultured healthy human macrophages transfected with hY3, an anti-SSA/Ro-associated ssRNA, 2) RNA isolated from freshly sorted human leukocytes/macrophages after Langendorff perfusion of three fetal hearts dying with CHB and three healthy gestational age-matched hearts, and 3) autopsy tissue from three additional human CHB hearts and one healthy heart. TLR ligation of macrophages with hY3 led to the upregulation of a panel of IFN transcripts, including SIGLEC1, a result corroborated using quantitative PCR. Using independent and agnostic bioinformatics approaches, CD45+CD11c+ and CD45+CD11c- human leukocytes flow sorted from the CHB hearts highly expressed type I IFN response genes inclusive of SIGLEC1. Furthermore, Siglec-1 expression was identified in the septal region of several affected fetal hearts. These data now provide a link between IFN, IFN-stimulated genes, and the inflammatory and possibly fibrosing components of CHB, positioning Siglec-1-positive macrophages as integral to the process.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30518570      PMCID: PMC6310077          DOI: 10.4049/jimmunol.1800357

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block.

Authors:  Robert M Clancy; Anca D Askanase; Raj P Kapur; Efstathia Chiopelas; Natalie Azar; M Eugenia Miranda-Carus; Jill P Buyon
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

2.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

3.  Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.

Authors:  Carolina Llanos; Deborah M Friedman; Amit Saxena; Peter M Izmirly; Chung-E Tseng; Renata Dische; Rosanna G Abellar; Marc Halushka; Robert M Clancy; Jill P Buyon
Journal:  Rheumatology (Oxford)       Date:  2012-02-03       Impact factor: 7.580

Review 4.  Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.

Authors:  J P Buyon; R M Clancy; D M Friedman
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

5.  High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.

Authors:  Anna R Lisney; Franziska Szelinski; Karin Reiter; Gerd R Burmester; Thomas Rose; Thomas Dörner
Journal:  Ann Rheum Dis       Date:  2017-05-13       Impact factor: 19.103

6.  Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.

Authors:  Robert M Clancy; Androo J Markham; Joanne H Reed; Miroslav Blumenberg; Marc K Halushka; Jill P Buyon
Journal:  J Autoimmun       Date:  2015-10-01       Impact factor: 7.094

7.  Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.

Authors:  Sabina A Islam; Daniel S Chang; Richard A Colvin; Mike H Byrne; Michelle L McCully; Bernhard Moser; Sergio A Lira; Israel F Charo; Andrew D Luster
Journal:  Nat Immunol       Date:  2011-01-09       Impact factor: 25.606

8.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

9.  Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Authors:  Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R Grün; Marta Steinbrich-Zöllner; Marina Backhaus; Thomas Häupl; Martin Rudwaleit; Gabriela Riemekasten; Andreas Radbruch; Falk Hiepe; Gerd-Rüdiger Burmester; Andreas Grützkau
Journal:  Arthritis Rheum       Date:  2008-04

10.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Authors:  Damien Chaussabel; Charles Quinn; Jing Shen; Pinakeen Patel; Casey Glaser; Nicole Baldwin; Dorothee Stichweh; Derek Blankenship; Lei Li; Indira Munagala; Lynda Bennett; Florence Allantaz; Asuncion Mejias; Monica Ardura; Ellen Kaizer; Laurence Monnet; Windy Allman; Henry Randall; Diane Johnson; Aimee Lanier; Marilynn Punaro; Knut M Wittkowski; Perrin White; Joseph Fay; Goran Klintmalm; Octavio Ramilo; A Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

View more
  9 in total

Review 1.  Common innate pathways to autoimmune disease.

Authors:  David Langan; Noel R Rose; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2020-02-10       Impact factor: 3.969

Review 2.  Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis.

Authors:  Elena V Gerasimova; Tatiana V Popkova; Daria A Gerasimova; Tatiana V Kirichenko
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Authors:  Peter Izmirly; Mimi Kim; Deborah M Friedman; Nathalie Costedoat-Chalumeau; Robert Clancy; Joshua A Copel; Colin K L Phoon; Bettina F Cuneo; Rebecca E Cohen; Kimberly Robins; Mala Masson; Benjamin J Wainwright; Noel Zahr; Amit Saxena; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2020-07-21       Impact factor: 24.094

Review 4.  Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy.

Authors:  Przemyslaw Wielgat; Karol Rogowski; Katarzyna Niemirowicz-Laskowska; Halina Car
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 5.  Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms.

Authors:  Chunye Zhang; Ming Yang; Aaron C Ericsson
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 6.  Autoimmune Congenital Heart Block: A Review of Biomarkers and Management of Pregnancy.

Authors:  Sara De Carolis; Cristina Garufi; Ester Garufi; Maria Pia De Carolis; Angela Botta; Sara Tabacco; Silvia Salvi
Journal:  Front Pediatr       Date:  2020-12-22       Impact factor: 3.418

7.  Alternative splicing signatures of congenital heart disease and induced pluripotent stem cell-derived cardiomyocytes from congenital heart disease patients.

Authors:  Xiang Xu; Renchao Zou; Xiaoyong Liu; Qianqian Su
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

8.  Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block.

Authors:  Hemant Suryawanshi; Robert Clancy; Pavel Morozov; Marc K Halushka; Jill P Buyon; Thomas Tuschl
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

9.  Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.

Authors:  Malin Hedlund; Gudny Ella Thorlacius; Margarita Ivanchenko; Vijole Ottosson; Nikolaos Kyriakidis; Linda Lagnefeldt; Joanna Tingström; Allan Sirsjö; Anders A Bengtsson; Emma Aronsson; Kristina Gemzell-Danielsson; Lars Ronnblom; Gunnar Bergman; Alexander Espinosa; Sven-Erik Sonesson; Maija-Leena Eloranta; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2020-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.